MATREMBOS Trademark

Trademark Overview

On Tuesday, June 17, 2008, a trademark application was filed for MATREMBOS with the United States Patent and Trademark Office. The USPTO has given the MATREMBOS trademark a serial number of 77501064. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 6, 2017. This trademark is owned by AstraZeneca AB. The MATREMBOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes
matrembos

General Information

Serial Number77501064
Word MarkMATREMBOS
Filing DateTuesday, June 17, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 6, 2017
Registration Number3924437
Registration DateTuesday, March 1, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Friday, October 6, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 1, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Monday, November 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 5, 2010EXAMINER'S AMENDMENT ENTERED
Friday, November 5, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 5, 2010EXAMINERS AMENDMENT E-MAILED
Friday, November 5, 2010EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 6, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2010NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2010NON-FINAL ACTION WRITTEN
Wednesday, March 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 3, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 3, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 4, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 4, 2009INQUIRY TO SUSPENSION E-MAILED
Friday, September 4, 2009SUSPENSION INQUIRY WRITTEN
Monday, August 17, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, August 17, 2009ASSIGNED TO LIE
Tuesday, February 17, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 17, 2009LETTER OF SUSPENSION E-MAILED
Tuesday, February 17, 2009SUSPENSION LETTER WRITTEN
Friday, September 19, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 19, 2008NON-FINAL ACTION E-MAILED
Friday, September 19, 2008NON-FINAL ACTION WRITTEN
Thursday, September 18, 2008ASSIGNED TO EXAMINER
Friday, June 20, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

matrembos pharmaceutical treatment preparations pain inflammation cancer diabetes systems infection respiratory